Chronic hepatitis C: This and the new era of treatment
作者： Gaetano Bertino , Annalisa Ardiri , Maria Proiti , Giuseppe Rigano , Evelise Frazzetto
DOI: 10.4254/WJH.V8.I2.92
关键词: Boceprevir 、 Telaprevir 、 Virology 、 Medicine 、 Dasabuvir 、 Ombitasvir 、 Pediatrics 、 Simeprevir 、 Daclatasvir 、 Faldaprevir 、 Hepatitis C
摘要: Over the last years it has started a real revolution in treatment of chronic hepatitis C. This occurred for availability direct-acting antiviral agents that allow to reach sustained virologic response approximately 90% cases. In near future further progress will be achieved with use pan-genotypic drugs high efficacy but without side effects.
sci-hub.st 参考文章(134)
G. Bertino, A.M. Ardiri, G.S. Calvagno, N. Bertino, P.M. Boemi, Prognostic and diagnostic value of des-gamma-carboxy prothrombin in liver cancer Drug News & Perspectives. ,vol. 23, pp. 498- 508 ,(2010) , 10.1358/DNP.2010.23.8.1444236
Osamu Yokosuka, Masao Omata, Tatsuo Kanda, Antiviral therapy for "difficult-to-treat" hepatitis C virus-infected patients. Chinese Medical Journal. ,vol. 126, pp. 4568- 4574 ,(2013)
Amit Khatri, Rajeev M. Menon, Thomas C. Marbury, Eric J. Lawitz, Thomas J. Podsadecki, Victoria M. Mullally, Bifeng Ding, Walid M. Awni, Barry M. Bernstein, Sandeep Dutta, Pharmacokinetics and safety of co-administered paritaprevir plus ritonavir, ombitasvir, and dasabuvir in hepatic impairment Journal of Hepatology. ,vol. 63, pp. 805- 812 ,(2015) , 10.1016/J.JHEP.2015.05.029
S Zeuzem, R Flisiak, JM Vierling, W Mazur, Giuseppe Mazzella, S Thongsawat, D Abdurakhmanov, N Van Kinh, P Calistru, J Heo, C Stanciu, M Gould, M Makara, S‐J Hsu, P Buggisch, D Samuel, D Mutimer, B Nault, M Merz, W Bao, LH Griffel, C Brass, NV Naoumov, ESSENTIAL II Study Group, Hugo Tanno, Fernando Bessone, Ruben Terg, Bernardo Frider, Romina Bertuzzi, Paul Desmond, Amany Zekry, Martin Weltman, Jacob George, Darrell Crawford, Gail Matthews, Christophe Moreno, Hans Van Vlierberghe, Hendrik Reynaert, Michael Gould, Samuel Lee, Alnoor Ramji, Edward Tam, Paul Marotta, Eric Yoshida, Florence Wong, Jordan Feld, Didier Samuel, Patrick Marcellin, Laurent Alric, Jean‐Pierre Zarski, Fabien Zoulim, Peter Buggisch, Holger Hinrichsen, Tobias Goeser, Stefan Zeuzem, Peter Galle, Thomas Berg, Eckart Schott, Jens Rasenack, Guido Gerken, Hans Wedemeyer, Owen Tsang, Man‐Fung Yuen, Henry Chan, Aric Josun Hui, Mihaly Makara, Istvan Tornai, Judit Gervain, Ferenc Szalay, Marta Varga, Gabor Horvath, Bela Hunyady, Aron Vincze, Giuseppe Mazzella, Giovanni Battista Gaeta, Alfredo Alberti, Massimo Colombo, Pietro Andreone, Mario Rizzetto, Mario Angelico, Antonio Craxi, Antonino Picciotto, Paolo Sacchi, Maria Vinci, Pietro Invernizzi, Savino Bruno, Jeong Heo, Younjae Lee, Mong Cho, Sangyoung Han, Jinwoo Lee, Sanghoon Ahn, Youngsuk Lim, Seonggyu Hwang, Juan Sanchez, Linda Muñoz, Hector Maldonado, Wlodzimierz Mazur, Robert Flisiak, Maciej Jablkowski, Wieslaw Kryczka, Waldemar Halota, Petre Calistru, Cristina Prelipcean, Manuela Musa, Carol Stanciu, Mircea Manuc, Coman Tanasescu, Dan Dumitrascu, Djamal Abdurakhmanov, Vladimir Chulanov, Igor Nikitin, Konstantin Zhdanov, Elena Esaulenko, Marina Maevskaya, Olga Znoyko, Ricard Sola Lamoglia, Maria Buti Ferret, Javier Garcia‐Samaniego, Manuel Romero Gomez, Moises Diago, Jose Luis Calleja, Shih‐Jer Hsu, Wan‐Long Chuang, Tsung‐Hui Hu, Cheng‐Yuan Peng, Chi‐Yi Chen, Jia‐Horng Kao, Satawat Thongsawat, Wattana Sukeepaisarnjaroen, Teerha Piratvisuth, Tawesak Tanwandee, Piyawat Komolmit, Kosh Agarwal, David Mutimer, Ashley Brown, Graham Foster, Stuart McPherson, Stephen Ryder, John Poulos, Vinod Rustgi, Kip Lyche, Steven Omarro, John Vierling, Reem Ghalib, Umaprasanna Karnam, Craig Peine, Joseph Galati, John Person, Andrew De La Torre, None, Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment‐naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II) Alimentary Pharmacology & Therapeutics. ,vol. 42, pp. 829- 844 ,(2015) , 10.1111/APT.13342
Pasquale Caponnetto, Cristina Russo, Annalisa Di Maria, Jaymin B. Morjaria, Sheila Barton, Francesca Guarino, Elisa Basile, Maria Proiti, Gaetano Bertino, Rossella R. Cacciola, Riccardo Polosa, Circulating endothelial-coagulative activation markers after smoking cessation: a 12-month observational study European Journal of Clinical Investigation. ,vol. 41, pp. 616- 626 ,(2011) , 10.1111/J.1365-2362.2010.02449.X
D. Lavanchy, Evolving epidemiology of hepatitis C virus Clinical Microbiology and Infection. ,vol. 17, pp. 107- 115 ,(2011) , 10.1111/J.1469-0691.2010.03432.X
Michael G. Katze, Jamie L. Fornek, Robert E. Palermo, Kathie-Anne Walters, Marcus J. Korth, Innate immune modulation by RNA viruses: emerging insights from functional genomics Nature Reviews Immunology. ,vol. 8, pp. 644- 654 ,(2008) , 10.1038/NRI2377
Thierry Poynard, John McHutchison, Michael Manns, Christian Trepo, Karen Lindsay, Zachary Goodman, Mei–Hsiu Ling, Janice Albrecht, PEG-fibrosis project group, Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology. ,vol. 122, pp. 1303- 1313 ,(2002) , 10.1053/GAST.2002.33023
Gaetano Bertino, Shirin Demma, Annalisa Ardiri, Maria Proiti, Giulia Malaguarnera, Nicoletta Bertino, Michele Malaguarnera, Mariano Malaguarnera, Hepatocellular carcinoma: novel molecular targets in carcinogenesis for future therapies. BioMed Research International. ,vol. 2014, pp. 203693- 203693 ,(2014) , 10.1155/2014/203693
Fred Poordad, Christophe Hezode, Roger Trinh, Kris V. Kowdley, Stefan Zeuzem, Kosh Agarwal, Mitchell L. Shiffman, Heiner Wedemeyer, Thomas Berg, Eric M. Yoshida, Xavier Forns, Sandra S. Lovell, Barbara Da Silva-Tillmann, Christine A. Collins, Andrew L. Campbell, Thomas Podsadecki, Barry Bernstein, ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis The New England Journal of Medicine. ,vol. 370, pp. 1973- 1982 ,(2014) , 10.1056/NEJMOA1402869